Talphera, Inc. (TLPH)

USD 0.52

(4.1%)

Revenue Summary of Talphera, Inc.

  • Talphera, Inc.'s latest annual revenue in 2023 was 651 Thousand USD , down -63.24% from previous year.
  • Talphera, Inc.'s latest quarterly revenue in 2024 Q2 was - USD , down 0.0% from previous quarter.
  • Talphera, Inc. reported a annual revenue of 1.77 Million USD in annual revenue 2022, down -37.15% from previous year.
  • Talphera, Inc. reported a annual revenue of 2.81 Million USD in annual revenue 2021, down -47.97% from previous year.
  • Talphera, Inc. reported a quarterly revenue of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Talphera, Inc. reported a quarterly revenue of 253 Thousand USD for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of Talphera, Inc. (2023 - 2013)

Historical Annual Revenue of Talphera, Inc. (2023 - 2013)

Year Revenue Revenue Growth
2023 651 Thousand USD -63.24%
2022 1.77 Million USD -37.15%
2021 2.81 Million USD -47.97%
2020 5.41 Million USD 136.61%
2019 2.28 Million USD 6.42%
2018 2.15 Million USD -73.1%
2017 7.99 Million USD -53.94%
2016 17.35 Million USD -9.89%
2015 19.26 Million USD 269.24%
2014 5.21 Million USD -82.32%
2013 29.5 Million USD 0.0%

Peer Revenue Comparison of Talphera, Inc.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 99.885%
Embecta Corp. 1.12 Billion USD 99.942%
ANI Pharmaceuticals, Inc. 486.81 Million USD 99.866%
Dynavax Technologies Corporation 232.28 Million USD 99.72%
Esperion Therapeutics, Inc. 116.33 Million USD 99.44%
Pacira BioSciences, Inc. 674.97 Million USD 99.904%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD 98.713%
Sunshine Biopharma, Inc. 24.09 Million USD 97.298%
SCYNEXIS, Inc. 140.14 Million USD 99.535%
China SXT Pharmaceuticals, Inc. 1.92 Million USD 66.243%
Cosmos Health Inc. 53.37 Million USD 98.78%
Journey Medical Corporation 79.18 Million USD 99.178%
Sunshine Biopharma, Inc. 24.09 Million USD 97.298%
Safety Shot Inc 202.67 Thousand USD -221.212%
Alpha Teknova, Inc. 36.68 Million USD 98.225%
Intra-Cellular Therapies, Inc. 464.37 Million USD 99.86%
Bright Green Corporation 401.49 Thousand USD -62.146%
Procaps Group, S.A. 409.92 Million USD 99.841%
Theratechnologies Inc. 81.76 Million USD 99.204%
Harrow Health, Inc. 130.19 Million USD 99.5%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 94.888%
Biofrontera Inc. 34.07 Million USD 98.089%
DURECT Corporation 8.54 Million USD 92.384%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 99.893%
Cronos Group Inc. 88.84 Million USD 99.267%
OptiNose, Inc. 70.98 Million USD 99.083%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 99.853%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD 90.005%
Organogenesis Holdings Inc. 433.14 Million USD 99.85%
Guardion Health Sciences, Inc. 12.24 Million USD 94.685%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 98.354%
Radius Health, Inc. 2.88 Billion USD 99.977%
Universe Pharmaceuticals INC 32.3 Million USD 97.985%
ProPhase Labs, Inc. 44.38 Million USD 98.533%
Phibro Animal Health Corporation 1.01 Billion USD 99.936%
Procaps Group S.A. 409.92 Million USD 99.841%
Alvotech 91.43 Million USD 99.288%
TherapeuticsMD, Inc. 1.3 Million USD 50.0%
Viatris Inc. 15.42 Billion USD 99.996%
Rockwell Medical, Inc. 83.61 Million USD 99.221%
Aytu BioPharma, Inc. 81 Million USD 99.196%
SIGA Technologies, Inc. 139.91 Million USD 99.535%
Tilray Brands, Inc. 788.94 Million USD 99.917%
Lifecore Biomedical, Inc. 128.26 Million USD 99.492%
Shineco, Inc. 9.8 Million USD 93.358%
PetIQ, Inc. 1.1 Billion USD 99.941%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -5325.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.966%
Alimera Sciences, Inc. 80.75 Million USD 99.194%
Silver Spike Investment Corp. 11.72 Million USD 94.446%
Assertio Holdings, Inc. 152.06 Million USD 99.572%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD 88.819%
Clever Leaves Holdings Inc. 17.41 Million USD 96.262%
Cyclo Therapeutics, Inc. 1.07 Million USD 39.521%
Avadel Pharmaceuticals plc 27.96 Million USD 97.672%
Hempacco Co., Inc. 4.04 Million USD 83.909%
Alvotech 91.43 Million USD 99.288%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 99.794%
Lantheus Holdings, Inc. 1.29 Billion USD 99.95%
Currenc Group, Inc. 53.25 Million USD 98.778%
Kamada Ltd. 144.75 Million USD 99.55%
Indivior PLC 1.09 Billion USD 99.94%
Evoke Pharma, Inc. 5.18 Million USD 87.434%
Flora Growth Corp. 76.07 Million USD 99.144%
Cyclo Therapeutics, Inc. 1.07 Million USD 39.521%
Evolus, Inc. 202.08 Million USD 99.678%
HUTCHMED (China) Limited 837.99 Million USD 99.922%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 99.899%
Akanda Corp. 2.16 Million USD 69.862%